Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2026 16:33 ET | Source: Aptera Motors Corp

Aptera Motors Announces Closing of $9 Million Public Offering

Aptera (NASDAQ: SEV) closes $9M public offering with warrants for up to $18M total, advancing solar electric vehicle production and validation efforts.
January 23, 2026 08:00 ET | Source: Aptera Motors Corp

Aptera Motors Announces Pricing of $9 Million Public Offering

Aptera today announced the pricing of its public offering for the purchase and sale of 4,500,000 shares of its Class B common stock.
December 05, 2025 10:50 ET | Source: Aptera Motors Corp

Aptera Co-CEO Chris Anthony to Participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference

Aptera announced today that Co-CEO Chris Anthony will participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference.
January 27, 2025 20:30 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
September 20, 2024 08:30 ET | Source: Fortress Biotech, Inc.

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...
May 16, 2024 08:00 ET | Source: Fortress Biotech, Inc.

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
May 15, 2024 16:01 ET | Source: Journey Medical Corporation

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
February 02, 2024 08:00 ET | Source: GRI Bio, Inc.

GRI Bio Announces Pricing of $5.5 Million Public Offering

LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell...
August 17, 2023 08:00 ET | Source: Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd. Announces the Separate Trading of its Ordinary Shares, Warrants, and Rights, Commencing on August 21, 2023

New York, NY, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Bukit Jalil Global Acquisition 1 Ltd. (the “Company”) (Nasdaq: BUJA), a blank check company, today announced that, commencing on August 21, 2023,...
April 06, 2022 08:30 ET | Source: Celsion Corporation

CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

LAWRENCEVILLE, NJ, April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...